SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 5,700 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Mr. Jiguang Qu 2005 'den beri şirketle birlikte olan SSY Group Ltd 'in Executive Chairman of the Board 'ıdır.
SSY GROUP LIMITED hissesinin fiyat performansı nasıl?
SSY GROUP LIMITED 'in mevcut fiyatı $0.4025 'dir, son işlem günde 0% azalmış etti.
SSY Group Ltd için ana iş temaları veya sektörler nelerdir?
SSY Group Ltd Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
SSY Group Ltd 'in piyasa değerlemesi nedir?
SSY Group Ltd 'in mevcut piyasa değerlemesi $1.1B 'dir
SSY Group Ltd al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 6 analist SSY Group Ltd için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 5 al, 1 tut, 0 sat ve 4 güçlü sat içermektedir